Investor
Global BioAccess Fund
New York · United States
Global BioAccess Fund invests in early-stage companies developing novel therapeutics and devices for oncology, cardiovascular, CNS, and rare diseases.
Stage
Pre-seed–Series A
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Global
Sectors
About
The firm partners with companies to create future medicines. They invest in transformative technologies addressing unmet needs in oncology, immunology, cardiovascular, and rare diseases. The fund provides capital to early-stage companies specifically to support IND submission and clinical trials. They collaborate with entrepreneurs who are advancing frontiers in science and technology across various medical specialities.
How to approach
Send an enquiry to the firm's general information email address.
Portfolio · 4 · tap a company to read about it